Cell-based Gene Therapy May Offer Long-term Treatment for Hemophilia A, Mouse Study Suggests

Cell therapy with endothelial progenitor cells and stem cells genetically engineered to produce a functional clotting factor VIII (FVIII) may provide a stable and long-term treatment for hemophilia A, a mouse study has found. Read the full story here.

0 comments

Subscribe and Get Breaking News Sent to Your Inbox!

  • White Instagram Icon
  • White Facebook Icon
  • LinkedIn
  • Twitter

© 2019- 2021 HEMO TIMES IS A SUBSIDIARY OF RARE HEALTH NETWORK, LLC